An earlier online version of the paper contained some typographical errors in the [Table 3](#t0005){ref-type="table"}, [Table 4](#t0010){ref-type="table"}. These Tables have now been corrected and the corrections do not change the results or conclusions of the study. The authors apologize for the errors.Table 3Effects of omega-3 supplements on serum lipids by different genotypes at *NOS3* (rs1799983).[†](#tf0005){ref-type="table-fn"}Table 3Total omega-3 supplementsFish oil supplementsFlaxseed oil supplementsControlAA/AC (*n* = 10)CC (*n* = 90)AA/AC (*n* = 3)CC (*n* = 53)AA/AC (*n* = 7)CC (*n* = 37)AA/AC (*n* = 11)CC (*n* = 39)HDL-CBaseline1.13 (0.30)1.17 (0.31)1.38 (0.37)1.13 (0.30)1.03 (0.21)1.21 (0.32)1.17 (0.15)1.18 (0.20)After intervention1.32 (0.29)1.21 (0.31)1.64 (0.33)1.21 (0.29)1.19 (0.13)1.22 (0.33)1.22 (0.19)1.26 (0.26)Change0.19 (0.12)0.06 (0.22)0.26 (0.14)0.08 (0.23)0.16 (0.11)0.03 (0.19)0.09 (0.10)0.07 (0.19)LDL-CBaseline3.02 (0.69)2.94 (0.86)3.24 (1.02)2.95 (0.83)2.93 (0.58)2.94 (0.92)2.84 (0.54)3.14 (0.94)After intervention2.87 (0.75)2.79 (0.78)2.14 (0.31)2.71 (0.82)3.19 (0.66)2.91 (0.71)2.92 (0.63)3.08 (1.00)Change−0.15 (1.08)−0.17 (0.77)−1.10 (0.96)−0.27 (0.86)0.26 (0.9)−0.02 (0.59)0.19 (0.93)−0.11 (0.78)TCBaseline4.72 (0.98)4.71 (0.95)5.38 (1.45)4.66 (0.94)4.44 (0.65)4.77 (0.97)4.66 (0.80)4.95 (1.10)After intervention4.96 (1.13)4.71 (0.95)4.13 (0.41)4.60 (1.01)5.32 (1.17)4.86 (0.83)4.54 (0.75)5.23 (1.22)Change0.24 (1.39)−0.02 (0.75)−1.25 (1.04)−0.11 (0.76)0.88 (0.97)0.13 (0.72)0.06 (1.12)0.32 (0.94)TC/HDL-CBaseline4.30 (0.92)4.24 (1.13)3.93 (0.71)4.30 (1.11)4.46 (1.00)4.15 (1.18)4.02 (0.70)4.25 (1.00)After intervention3.90 (1.12)4.07 (1.14)2.58 (0.48)3.95 (1.01)4.46 (0.75)4.26 (1.30)3.75 (0.65)4.37 (1.73)Change−0.40 (1.03)−0.21 (0.86)−1.36 (0.32)−0.42 (0.78)0.00 (0.96)0.09 (0.89)−0.24 (0.83)0.13 (1.74)TG (log-transformed)Baseline0.48 (0.46)0.42 (0.51)0.65 (0.41)0.42 (0.47)0.41 (0.49)0.43 (0.57)0.45 (0.46)0.53 (0.49)After intervention0.40 (0.43)0.33 (0.54)0.19 (0.46)0.26 (0.51)0.49 (0.41)0.43 (0.58)0.47 (0.44)0.47 (0.50)Change−0.08 (0.31)−0.11 (0.39)−0.46 (0.15)−0.16 (0.37)0.08 (0.19)−0.03 (0.42)−0.02 (0.31)−0.08 (0.37)[^1]Table 4Effects of omega-3 supplements on serum lipids by different genotypes at *PPARG* (rs1801282).[†](#tf0010){ref-type="table-fn"}Table 4Total omega-3 supplementsFish oil supplementsFlaxseed oil supplementsControlGG/GC (*n* = 12)CC (*n* = 88)GG/GC (*n* = 8)CC (*n* = 48)GG/GC (*n* = 4)CC (*n* = 40)GG/GC (*n* = 5)CC (*n* = 45)HDL-CBaseline1.20 (0.28)1.16 (0.31)1.16 (0.31)1.14 (0.31)1.26 (0.26)1.17 (0.31)1.22 (0.13)1.18 (0.19)After intervention1.28 (0.25)1.22 (0.31)1.26 (0.25)1.23 (0.32)1.34 (0.31)1.20 (0.31)1.31 (0.12)1.25 (0.26)Change0.08 (0.27)0.07 (0.21)0.10 (0.29)0.09 (0.22)0.03 (0.22)0.05 (0.19)0.07 (0.13)0.08 (0.18)LDL-CBaseline3.35 (0.77)2.90 (0.84)3.19 (0.86)−0.26 (0.85)3.67 (0.51)0.05 (0.66)2.77 (0.58)3.11 (0.89)After intervention2.76 (0.68)2.80 (0.79)2.53 (0.63)2.92 (0.83)3.36 (0.39)2.86 (0.87)3.47 (0.54)3.00 (0.96)Change[⁎](#tf0015){ref-type="table-fn"}−0.54 (0.87)−0.12 (0.78)−0.65 (0.98)2.71 (0.84)−0.23 (0.47)2.92 (0.71)0.80 (0.68)−0.13 (0.78)TCBaseline5.23 (1.18)4.64 (0.89)4.92 (1.18)4.66 (0.94)5.85 (1.05)4.60 (0.85)4.60 (0.81)4.92 (1.06)After intervention4.91 (1.03)4.71 (0.96)4.66 (1.15)4.55 (0.98)5.49 (0.26)4.90 (0.91)5.27 (0.79)5.07 (1.20)Change−0.43 (0.94)0.07 (0.81)−0.43 (0.99)−0.14 (0.79)−0.42 (1.02)0.31 (0.78)0.61 (0.80)0.23 (0.99)TC/HDL-CBaseline4.49 (0.99)4.21 (1.13)4.38 (1.12)4.26 (1.10)4.71 (0.77)4.15 (1.17)3.75 (0.28)4.24 (0.98)After intervention3.97 (1.06)4.06 (1.14)3.86 (1.15)3.87 (1.03)4.25 (0.96)4.30 (1.24)4.04 (0.49)4.27 (1.66)Change−0.55 (1.24)−0.19 (0.83)−0.63 (1.51)−0.45 (0.65)−0.35 (0.07)0.11 (0.92)0.29 (0.41)0.03 (1.67)TG (log-transformed)Baseline0.56 (0.54)0.41 (0.49)0.42 (0.49)0.43 (0.46)0.85 (0.59)0.39 (0.54)0.49 (0.57)0.51 (0.47)After intervention0.42 (0.43)0.32 (0.54)0.32 (0.47)0.24 (0.51)0.67 (0.12)0.42 (0.56)0.81 (0.36)0.44 (0.48)Change−0.17 (0.41)−0.10 (0.38)−0.10 (0.37)−0.19 (0.37)−0.35 (0.55)0.02 (0.37)0.10 (0.20)−0.09 (0.37)[^2][^3]

[^1]: Values are presented as mean (SD). Total omega-3 supplement group is a combination of fish oil and flaxseed oil groups. HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides. No interaction between *NOS3* genotypes and omega-3 supplements for the lipid traits was observed.

[^2]: Values are presented as mean (SD). Total omega-3 supplement group is a combination of fish oil and flaxseed oil groups. HDL-C, high cv LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides.

[^3]: Significant interaction (p-interaction = 0.02) between the *PPARG* genotypes and the omega-3 supplements for the change in LDL-C was observed in the general linear model, after adjustment for age, sex, study centre, BMI and baseline value of corresponding outcome. *PPARG* G allele carriers had a higher increase in LDL-C level compared with CC carriers among control group (p = 0.022), while no difference was observed among omega-3 groups.
